A CME/MOC-Accredited Virtual Event in partnership
with International Cardio-Oncology Society (IC-OS)
Identifying, Managing and Mitigating Therapy-Related Adverse Events in Patients with Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma
International Cardio-Oncology Society (IC-OS) was pleased to recently partner with Dr. Neil Love and Research To Practice to create a multidisciplinary live webinar addressing some of the most commonly encountered adverse events arising in the treatment of chronic lymphocytic leukemia (CLL) and mantle cell leukemia (MCL). IC-OS immediate past president and cardio-oncologist Dr. Daniel Lenihan provided a review of the pathophysiology, incidence and optimal management strategies for the cardiologic toxicities associated with novel targeted agents. Dr. Neil Love discussed these issues with Drs Richard Furman from Weil Cornell Medicine and Lindsey Roeker from Memorial Sloan Kettering, who also reviewed several relevant cases we collected from an oncologist currently in practice.